Benchmarking Compliance Maturity 2017 Report
Life Science companies are constantly bombarded with new regulations, new technology and new business initiatives. They must find the optimal balance between risk and efficiency so that regulatory compliance does not stand in the way of digitalization, analytics, patient centricity, and more. We hear serious questions from the industry:
• Are we over-spending on time and resources, hampering efficiency and our bottom line?
• Are we underspending and running the risk of our compliance getting out-of-control?
What value will my company get from this report?
This study, based on a 2017 survey of the Danish Life Science industry, provides insight and recommends concrete actions to help companies balance their compliance efforts between risk and efficiency. Finding the optimal balance between these two extremes is critical, for it is here that compliance moves from being an obstacle into actually helping the company achieve its business goals.
This report is designed for Life Science professionals in IT, quality, regulatory, production, system owners, data owners, and management.